Диссертация (1025060), страница 28
Текст из файла (страница 28)
7, No. 3. Р. 345–354.141. The logistic EuroSCORE / F. Roques [et al.] // European Heart Journal. 2003.Vol. 24. Р. 881–882.181142. The Society of Thoracic Surgeons National Cardiac Surgery Database: currentrisk assessment / F.H. Edwards [et al.] // The Annals of Thoracic Surgery.
1997.Vol. 63. Р. 903–908.143. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome(SOURCE) Registry: A European registry of transcatheter aortic valveimplantation using the Edwards SAPIEN valve / M. Thomas [et al.] // Circulation.2010. Vol. 122. Р. 62–69.144. Three dimensional evaluation of the aortic annulus using multislice computertomography: are manufacturer's guidelines for sizing for percutaneous aorticvalve replacement helpful? / C.J.
Schultz [et al.] // European Heart Journal. 2010.Vol. 31, No. 7. Р. 849–856.145. Transcatheter aortic bioprosthesis dislocation: technical aspects and midtermfollow-up / G.P. Ussia [et al.] // EuroIntervention. 2012. Vol. 7, No. 11. Р. 1285–1292.146. Transcatheter aortic valve implantation: predictors of procedural success—theSiegburg–Bern experience / L. Buellesfeld [et al.] // European Heart Journal.2010. Vol. 31, No. 8. Р. 984–991.147.
Tubular heart valves from decellularized engineered tissue / Z.H. Syedain [et al.]// Annals of Biomedical Engineering. 2013. Vol. 41, No. 12. Р. 2645–2654.148. Tubular heart valves: a new tissue prosthesis design--preclinical evaluation of the3F aortic bioprosthesis / J.L. Cox [et al.] // The Journal of Thoracic andCardiovascular Surgery. 2005. Vol. 130, No.
2. Р. 520–527.149. Valvular heart disease: the next cardiac epidemic / J.L. d'Arcy [et al.] // Heart.2011. Vol. 97. Р. 91–93.150. Vascular complications with transcatheter aortic valve implantation using the 18Fr Medtronic CoreValve System: the Rotterdam experience / N.M. Van Mieghem[et al.] // EuroIntervention. 2010. Vol.
5. Р. 639–673.151. Very late outcomes for mitral valve replacement with the Carpentier-Edwardspericardial bioprosthesis: 25-year follow-up of 450 implantations / T.182Bourguignon [et al.] // The Journal of Thoracic and Cardiovascular Surgery. 2014.Vol. 148, No. 5. P. 2004–2011.152. Vesely I.
Invited Review Transcatheter Valves: A Brave New World // TheJournal of Heart Valve Disease. 2010. Vol. 19. Р. 543–558.153. Vesely I. The evolution of bioprosthetic heart valve design and its impact ondurability // Cardiovascular Pathology. 2003. Vol. 12.
Р. 227–286.154. Vesey I., Boughner S., Tong T. Tissue buckling as a mechanism of bioprostheticvalve failure // The Annals of Thoracic Surgery. 1988. Vol. 48. Р. 302–308.155. Xenopericardial graft selection for valve apparatus of transcatheter heart valvebioprosthesis / E. A. Ovcharenko [et al.] // Biomedical Engineering. 2016.
Vol.49, No. 5. P. 253–257.156. Ye J., Soon J.L., Webb J. Aortic valve replacement vs. transcatheter aortic valveimplantation: Patient selection // Annals of Cardiothoracic Surgery. 2012. Vol. 1,No. 2. Р. 96–99.157. Zannis K., Folliguet T., Laborde F. New sutureless aortic valve prosthesis: anothertool in less invasive aortic valve replacement // Current Opinion in Cardiology.2012. Vol. 27, No. 2. Р. 125–129.158.
Zhu D., Zhao Q. Dynamic normal aortic root diameters: implications for aorticroot reconstruction // The Annals of Thoracic Surgery. 2011. Vol. 91, No. 2. Р.485–489..